Monica Maccaferri Selected Research

Monica Maccaferri Research Topics

6	Neoplasms (Cancer) 02/2022 - 02/2021
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 01/2020
4	Mycoses (Diseases, Fungus) 01/2020 - 07/2010
3	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 09/2014
2	Infections 01/2020 - 01/2013
2	Invasive Fungal Infections 01/2020 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2015 - 02/2010
2	Philadelphia Chromosome 02/2010 - 07/2009
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2022
1	Eosinophilia 02/2022
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2022
1	Inflammation (Inflammations) 01/2022
1	Genomic Instability 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022
1	Trisomy (Trisomies) 01/2021
1	Leukemia 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2016
1	Aspergillosis 01/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2010

3	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 01/2020
3	ibrutinibIBA 01/2021 - 01/2020
2	AntigensIBA 01/2019 - 01/2013
1	pegaspargase (Oncaspar)FDA Link 03/2022
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 02/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	KynurenineIBA 01/2022
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	Cysteine (L-Cysteine)FDA Link 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	tapotoclaxIBA 01/2021
1	venetoclaxIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2019
1	Staphylococcal Protein A (Protein A)IBA 01/2019
1	Filgrastim (Neupogen)FDA Link 01/2018
1	Biosimilar PharmaceuticalsIBA 01/2018
1	EnzymesIBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	Asparaginase (Elspar)FDA Link 03/2015
1	ruxolitinibIBA 09/2014
1	Sodium Glutamate (Accent)IBA 07/2010
1	Imatinib Mesylate (Gleevec)FDA Link 02/2010
1	Tyrosine Kinase InhibitorsIBA 07/2009
1	Interferon-alpha (Interferon Alfa)IBA 07/2009